Stay updated on Inhaled GB0139 for Idiopathic Pulmonary Fibrosis Clinical Trial
Sign up to get notified when there's something new on the Inhaled GB0139 for Idiopathic Pulmonary Fibrosis Clinical Trial page.

Latest updates to the Inhaled GB0139 for Idiopathic Pulmonary Fibrosis Clinical Trial page
- Check7 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has undergone significant changes regarding the clinical trial for Idiopathic Pulmonary Fibrosis (IPF), including updates to the study's design and collaborators. Notably, the previous detailed description of the trial's methodology and inclusion/exclusion criteria has been removed, while the blinding and collaboration details have been retained.SummaryDifference20%
- Check29 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check36 days agoNo Change Detected
- Check72 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check87 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
- Check94 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
Stay in the know with updates to Inhaled GB0139 for Idiopathic Pulmonary Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inhaled GB0139 for Idiopathic Pulmonary Fibrosis Clinical Trial page.